About Allergan
Allergan is a Healthcare company based in Madison (United States) founded in 1948 by Gavin S Herbert, and was acquired by Pharmaron in March 2021. A portfolio of generic medicines is developed and manufactured. Allergan has completed 28 acquisitions, including Akarna Therapeutics, Anterios and AqueSys. Its focus areas include Diversified Pharmaceuticals and Drugs. Its competitors include Roivant Sciences, AbbVie and Gilead; 1 of its 3 listed competitors has raised funding.
Company details
Allergan was founded in 1948 in Madison, United States, as a pharmaceutical company. Generic medicines are developed and manufactured, with focus placed on therapeutic areas including dermatology, aesthetics, central nervous system disorders, eye care, womens health, urology, gastrointestinal and cystic fibrosis treatments, cardiovascular conditions, and infectious diseases. Operations are centered in the United States, supporting a range of medical needs through established production processes.
- Headquarters Madison, United States
- Founders Gavin S Herbert
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website allergan.com
- Social LinkedIn
- Acquired by Pharmaron (Mar 2021)
- InvestorsAbbVie
& 7 more
- Investments & AcquisitionsAkarna Therapeutics
& 27 more
- Acquired by
Associated legal entities of Allergan
Allergan is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Abbvie Healthcare India Private Limited CIN U85190KA2008PTC048318 | Active | 18 Nov 2008 | Bangalore, Karnataka | ₹179 Cr | 157 | 3 | View details |
| Allergan India Private Limited CIN U99999MH1994PTC079377 | Active | 04 Jul 1994 | Maharashtra, India | $56.9M | View details |
Apps and channels of Allergan
Allergan publishes 1 mobile app with over 500K+ downloads.
Funding Insights of Allergan
- Total Rounds 8
- First Round $226,281
(Mar 2008)
- Investors Count 4
All 8 funding rounds of Allergan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2018 | Post-IPO | β | β | ||
| Sep 2011 | $4M | Grant | β | β | |
| Mar 2010 | $340,859 | Grant | β | β | |
| Sep 2009 | $2.76M | Grant | β | β | |
| Sep 2009 | $1.7M | Grant | β | β | |
| Aug 2008 | $312,655 | Grant | β | β | |
| Jul 2008 | $148,215 | Grant | β | β | |
| Mar 2008 | $226,281 | Grant | β | β |
8 investors in total: 7 institutional and 1 angel.
Investors in Allergan
Allergan has secured backing from 8 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include AbbVie, Pharmaron and Pfizer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| sbir.nih.gov | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Administers health care and support for military personnel and operations. | health.mil | Falls Church, United States | ||
Drug discovery and development services for small molecules are provided. | 2003 | pharmaron.com | Beijing, China | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | abbvie.com | Chicago, United States | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | pfizer.com | New York, United States | |
CI Carl Icahn | unknown_deda00dd56164da19 | |||
Manufacturer of generic products | 1956 | actavis.com | Parsippany Troy Hills, United States |
Investor details for Allergan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Abbvie Healthcare India Private Limited (Allergan)
The board of Abbvie Healthcare India Private Limited currently have 3 directors; the longest-serving is Suresh Pattathil, appointed in 2022. 22 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Suresh Pattathil DIN 02748206 | Director | 25 Aug 2022 | 4 yrs 2 mo | Abbvie Healthcare India Private Limited |
| Vidhan Kedia DIN 06718606 | Director | 25 Jan 2023 | 3 yrs 9 mo | Abbvie Healthcare India Private Limited |
| Hong Liu Shi DIN 10424175 | Director | 11 Jan 2024 | 2 yrs 10 mo | Abbvie Healthcare India Private Limited |
People of Allergan
1491 people are tracked at Allergan (744 in leadership, 12 in board & advisors, 735 in team).
| Name | Role | Group |
|---|---|---|
Gavin S Herbert | Founder | Leadership |
Dana Overbey | Global Sr Director Vendor Management Office And Technology Asset Management | Leadership |
Lauren Yarnell | Executive Assistant To The Svp, Abbvie & President, Specialty & U.s. Therapeutics Operations | Leadership |
Martin Hayes | Chief Of Staff, Global Neuroscience & Ophthalmology Research | Leadership |
Brad Pignatello | Director Ii, Payer Strategy Eye Care - US Market Access | Leadership |
Bruce Dannan | Director, Commercial Business Technology | Leadership |
Aimee Marx | Head Of Marketing US Patient Services | Leadership |
Bardia Akbari | Vice President - Development Operations Oncology | Leadership |
Sarah Cantor | Marketing Director - Access, Advocacy, And Non-retail | Leadership |
Nisha Patel Burns | Senior Vice President, AbbVie and President, Specialty and U.S. Therapeutics Operations | Leadership |
Michael Schaffer | Director Ii, Neurology Franchise Lead | Leadership |
Mohamed Haytham | General Manager - North Africa | Leadership |
Amanda Arlis | Director | Leadership |
Katie Stromsborg | Director Of Business Training And Development | Leadership |
Ana Alzugaray Beitia | CFO Spain | Leadership |
Alicia Subasinghe | Senior Director, Patient Advocacy | Leadership |
April Hughes | Associate Marketing Director, Immunology | Leadership |
Paula Lima | Oncology Patient (consumer) Marketing Associate Director | Leadership |
Cormac Dalton | Vice President Sterile Manufacturing | Leadership |
Edgar Torres | Director, Transformation | Leadership |
1471 more people are available in the full profile.
Complete people profiles for Allergan
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Allergan
Figures of Abbvie Healthcare India Private Limited, the primary company behind Allergan, for FY 2025. Revenue was ₹179 Cr (+7% year on year). Net loss was -₹1.11 Cr (-1% margin). EBITDA was ₹8.42 Cr (5% margin). Revenue has grown at a compounded annual rate of +15% over three years and +10% over five years.
- ₹179 CrRevenue · FY 2025 · +7% YoY
- -₹1.11 CrNet loss · -1% margin
- ₹8.42 CrEBITDA · 5% margin
- ₹2.15 CrPaid-up capital
- 157Employees (provident fund records)
- +15%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Abbvie Healthcare India Private Limited are on its company page.
Detailed financial statements for Allergan
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Allergan
Allergan has strategically engaged in corporate development activities, having acquired 28 companies. Notable acquisitions include Akarna Therapeutics, Anterios and AqueSys.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Brand of skin care products | envymedical.com | Long Beach, United States | 1999 | Mar 2019 | β’β’β’β’ | |
Botulinum neurotoxins are developed for musculoskeletal pain treatment. | bonti.com | Newport Beach, United States | 2015 | Sep 2018 | $195M | |
Company offering solutions for cell growth and tissue repair through their Elastin technology | elastagen.com | Sydney, Australia | 2003 | Feb 2018 | $95M | |
Oral small molecule drugs are developed for reproductive health issues. | reprosrx.com | The Woodlands, United States | 1987 | Dec 2017 | β’β’β’β’ | |
Anti-aging skin care products are developed using growth factor technology. | regenica.com | San Diego, United States | 2008 | Jul 2017 | β’β’β’β’ | |
Silicone gel implant delivery devices are manufactured for surgical use. | kellerfunnel.com | Stuart, United States | 2009 | Jun 2017 | β’β’β’β’ | |
Controlled cooling technology is developed for non-surgical fat reduction. | zeltiq.com | Pleasanton, United States | 2005 | Feb 2017 | $2.47B | |
Tissue repair products for regenerative medicine are developed and marketed. | lifecell.com | United States | 1986 | Dec 2016 | $2.9B | |
Developer of drugs improve cognition and behavioral symptoms associated with Alzheimer’s disease | chasepharmaceuticals.com | United States | 2007 | Nov 2016 | $125M | |
Therapeutics for medical treatments are developed by Tobira Therapeutics. | tobiratherpeutics.com | 2006 | Nov 2016 | β’β’β’β’ |
Complete acquisition details for Allergan
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Allergan
17 dated milestones of Allergan across 73 years, from founding to its latest funding, stage changes and deals.
- Founded Allergan is founded.
- Funding First funding round of $226K.
- Exit Acquired by Actavis.
- Exit Acquired by Pfizer.
- Acquisition Acquires Tobira Therpeutics.
- Acquisition Acquires Chase Pharmaceuticals.
- Acquisition Acquires LifeCell.
- Acquisition Acquires Zeltiq.
- Acquisition Acquires Keller Medical.
- Acquisition Acquires Regenica.
- Acquisition Acquires Repros Therapeutics.
- Acquisition Acquires Elastagen.
- Funding Latest funding round, Post-IPO,.
- Acquisition Acquires Bonti.
- Acquisition Acquires Envy Medical.
- Exit Acquired by AbbVie.
- Exit Acquired by Pharmaron.
Competitors of Allergan
Allergan has 3 listed competitors in our database, 1 of them funded. They include Roivant Sciences, AbbVie and Gilead.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| roivant.com | 2014 | New York, United States | $1.3B | 662 | Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | |
| abbvie.com | 2012 | Chicago, United States | 8,667 | Biopharmaceutical research and drug development are conducted globally by AbbVie. | ||
| gilead.com | 1987 | Foster, United States | 4,267 | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others |
Detailed competitors of Allergan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Allergan
The website of Allergan (allergan.com) receives about 7.2K visits a month.
- Monthly visits7.2K
▲ 7.1% vs previous month
Websites whose visitors overlap most with Allergan. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| alcon.com | 100% | 171K | #286,128 | View details | |
| lilly.com | 100% | 4.9M | #13,252 | View details | |
| abbott.com | 96% | 917.2K | #65,577 | View details | |
| bms.com | 86% | 809.8K | #67,210 | View details | |
| baxter.com | 85% | 401.8K | #127,908 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 18 similar websites and full traffic analytics for Allergan
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Allergan (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Allergan
Complete news archive for Allergan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allergan
Allergan was founded in 1948 and raised its 1st funding round 60 years after it was founded.
Allergan is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Allergan was founded in 1948 in Madison, United States, as a pharmaceutical company. Generic medicines are developed and manufactured, with focus placed on therapeutic areas including dermatology, aesthetics, central nervous system disorders, eye care, womens health, urology, gastrointestinal and cystic fibrosis treatments, cardiovascular conditions, and infectious diseases. Operations are centered in the United States, supporting a range of medical needs through established production processes.
Allergan's top competitors include Roivant Sciences, AbbVie and Gilead.
Allergan has made 28 acquisitions, including Akarna Therapeutics, Anterios, and AqueSys.
Allergan is associated with 2 legal entities: Abbvie Healthcare India Private Limited, Allergan India Private Limited.
Yes. Allergan was acquired by Pharmaron in March 2021.
The legal entities of Allergan currently have 3 directors, including Suresh Pattathil, Hong Liu Shi, Vidhan Kedia.
Yes. Allergan publishes AllΔ, with over 500,000 downloads.

